Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Koelina Ganguly

Matched on OpenAlex author ID A5112901631. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 12

  1. NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXCL5/CXCR2 signaling axis. Co-author DOI 10.1016/j.canlet.2026.218269↗
  2. Hepatocytes promote liver metastasis of pancreatic cancer by providing serine. Co-author DOI 10.1038/s41586-026-11051-z↗
  3. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.drup.2024.101146↗
  4. Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-024-00562-5↗
  5. Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis. Co-author DOI 10.1038/s41388-022-02587-1↗
  6. Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2022.03.022↗
  7. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. Co-author DOI 10.1053/j.gastro.2021.09.017↗
  8. Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity. Co-author DOI 10.1053/j.gastro.2022.02.032↗
  9. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1128/mcb.00135-21↗
  10. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. Co-author DOI 10.1158/0008-5472.can-20-1293↗
  11. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. First author DOI 10.1016/j.ebiom.2019.03.056↗
  12. Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. First author DOI 10.1038/s41598-018-36328-w↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 11 shared papers, 2019–2026 · strength 1.69
  2. Jesse L. Cox · 6 shared papers, 2021–2026 · strength 1.00
  3. Sanchita Rauth · 6 shared papers, 2021–2024 · strength 0.91
  4. Sushil Kumar K · 6 shared papers, 2021–2024 · strength 0.91
  5. Ashu Shah · 5 shared papers, 2021–2024 · strength 0.78
  6. Moorthy Palanimuthu Ponnusamy · 5 shared papers, 2021–2024 · strength 0.78
  7. Maneesh Jain · 4 shared papers, 2022–2024 · strength 0.70
  8. Pranita Atri · 5 shared papers, 2019–2024 · strength 0.68
  9. Satyanarayana Rachagani · 4 shared papers, 2019–2024 · strength 0.52
  10. Paul M. Grandgenett · 3 shared papers, 2019–2026 · strength 0.48
  11. Apar Kishor Ganti · 2 shared papers, 2024–2026 · strength 0.48
  12. Sukhwinder Kaur · 4 shared papers, 2019–2022 · strength 0.43
  13. Michael Anthony Hollingsworth · 2 shared papers, 2022–2026 · strength 0.40
  14. Rakesh Bhatia · 3 shared papers, 2021–2023 · strength 0.39
  15. Ramesh Pothuraju · 2 shared papers, 2021–2026 · strength 0.38
  16. Joseph Carmicheal · 3 shared papers, 2019–2024 · strength 0.37
  17. Lynette M. Smith · 3 shared papers, 2019–2024 · strength 0.37
  18. Muzafar Ahmad Macha · 2 shared papers, 2019–2026 · strength 0.35
  19. Sushil Kumar · 2 shared papers, 2021–2024 · strength 0.32
  20. Parthasarathy Seshacharyulu · 2 shared papers, 2021–2024 · strength 0.29
  21. Christopher M. Thompson · 2 shared papers, 2022–2023 · strength 0.28
  22. Sanjib Chaudhary · 1 shared paper, 2026 · strength 0.27
  23. Imayavaramban Lakshmanan · 1 shared paper, 2026 · strength 0.27
  24. Subodh M. Lele · 1 shared paper, 2026 · strength 0.27
  25. Douglas E. Biancur · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.